Indorama Ventures

Photo

IVL Seeks new Battery Partner as Capchem Deal Folds

Thailand’s Indorama Ventures (IVL) says it is “continuing to assess” plans to build and operate a plant for “world-class” lithium-ion battery solvents at one of its petrochemical facilities on the US Gulf Coast, but no longer with Capchem USA, subsidiary of China’s Shenzen-Capchem Technology.

Photo

Indorama and Capchem Eye EV Battery Market

Thai-headquartered petrochemicals and polyester giant Indorama Ventures (IVL) and Capchem USA, a subsidiary of China’s Shenzhen Capchem Technology, are reviewing options for jointly building and operating a carbonate plant to supply the North American lithium-ion battery market.

Photo

IVL to Buy Brazilian Surfactants Maker Oxiteno

Indorama Ventures (IVL), a world leader in the PET market, is continuing its acquisition spree, in its latest move buying Brazil’s Oxiteno Indústria e Comércio, a subsidiary of Ultrapar Participações. In picking up the new asset, IVL said it will gain a unique portfolio in high-value surfactants and significantly expand its existing Integrated Oxides and Derivatives (IOD) business.

Photo

Indorama Developing US Oxides R&D Center

The Integrated Oxides & Derivatives (IOD) business of Indorama Ventures (IVL), Thailand-based global petrochemical producer best known as the world’s largest producer of PET resin, is developing a new technology center at The Woodlands, Texas.

Photo

Indorama Group Adds PET Capacity in India

Indo Rama Synthetics (India) Limited (IRSL), a subsidiary of global petrochemical producer and PET giant Indorama Ventures (IVL), plans to spend up to $82 million on upgrading equipment and adding capacity at its site in Nagpur, India. The investment foresees a new PET resin plant as well as additional balancing equipment and a large range of specialty yarns.

Photo

Grasim Sells Fertilizer Unit to Indorama

India’s Grasim Industries has agreed to sell its fertilizer business Indo Gulf Fertilisers (IGF) to Indorama India Private, a subsidiary of Singapore’s Indorama Corp., for a cash sum of about $355 million.

4 more articles

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.